RENHE PHARMACY CO.,LTD — Investor Relations & Filings
Renhe Pharmacy Co., Ltd. specializes in the research, development, manufacturing, and distribution of pharmaceutical products and health-related commodities. The company maintains a diverse portfolio encompassing over-the-counter (OTC) medications, traditional Chinese medicines (TCM), health supplements, and personal care items. Its core product lines address various therapeutic areas, including respiratory health, digestive disorders, gynecology, and pediatrics. Renhe is recognized for its established brand equity, operating well-known labels such as Renhe, Youka, and Fuyan. The company integrates modern pharmaceutical technology with traditional medicinal practices to produce high-quality healthcare solutions. Its operations are supported by a comprehensive supply chain and an extensive marketing network, focusing on providing accessible healthcare products to a broad consumer base.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 公司续聘2026年度审计机构的公告 | 2026-04-23 | Chinese | |
| 国泰海通证券股份有限公司关于仁和药业股份有限公司2025年度募集资金存放与实际使用情况的核查意见 | 2026-04-23 | Chinese | |
| 仁和药业股份有限公司年度募集资金存放、管理与使用情况专项报告 | 2026-04-23 | Chinese | |
| 内部控制审计报告-德皓内字[2026]00000065 | 2026-04-23 | Chinese | |
| 关于授权董事会制定2026年中期分红方案的公告 | 2026-04-23 | Chinese | |
| 关于2025年度计提资产减值准备的公告 | 2026-04-23 | Chinese |
Browse filings by year
28 years- 2026 28 filings
- 2025 99 filings
- 2024 77 filings
- 2023 79 filings
- 2022 80 filings
- 2021 115 filings
- 2020 108 filings
- 2019 69 filings
- 2018 43 filings
- 2017 43 filings
- 2016 93 filings
- 2015 100 filings
- 2014 74 filings
- 2013 106 filings
- 2012 114 filings
- 2011 79 filings
- 2010 60 filings
- 2009 66 filings
- 2008 40 filings
- 2007 73 filings
- 2006 79 filings
- 2005 38 filings
- 2004 24 filings
- 2003 26 filings
- 2002 18 filings
- 2001 6 filings
- 1998 1 filing
- 1996 1 filing
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 42930689 | 公司续聘2026年度审计机构的公告 | 2026-04-23 | Chinese | ||
| 42930682 | 国泰海通证券股份有限公司关于仁和药业股份有限公司2025年度募集资金存放与实际使用情况的核查意见 | 2026-04-23 | Chinese | ||
| 42930675 | 仁和药业股份有限公司年度募集资金存放、管理与使用情况专项报告 | 2026-04-23 | Chinese | ||
| 42930666 | 内部控制审计报告-德皓内字[2026]00000065 | 2026-04-23 | Chinese | ||
| 42930659 | 关于授权董事会制定2026年中期分红方案的公告 | 2026-04-23 | Chinese | ||
| 42930654 | 关于2025年度计提资产减值准备的公告 | 2026-04-23 | Chinese | ||
| 42930642 | 公司审计委员会对会计师事务所履行监督职责情况报告 | 2026-04-23 | Chinese | ||
| 42930637 | 2025年年度报告 | 2026-04-23 | Chinese | ||
| 42930626 | 公司2025年度独立董事述职报告 (王跃生-届满离任) | 2026-04-23 | Chinese | ||
| 42930622 | 公司关于第二期员工持股计划提前终止的公告 | 2026-04-23 | Chinese | ||
| 42930612 | 募集资金存放、管理与使用情况鉴证报告-德皓核字[2026]00001018 | 2026-04-23 | Chinese | ||
| 42930602 | 控股股东及其他关联方资金占用情况的-德皓核字[2026]00001019 | 2026-04-23 | Chinese | ||
| 42930588 | 公司董事会关于独立董事独立性自查情况的专项意见 | 2026-04-23 | Chinese | ||
| 42930579 | 关于使用自有资金进行投资理财的公告 | 2026-04-23 | Chinese | ||
| 42930574 | 非经营性资金占用及其他关联资金往来情况汇总表 | 2026-04-23 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
RENHE PHARMACY CO.,LTD via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/53730/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=53730 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=53730 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=53730 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 53730}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for RENHE PHARMACY CO.,LTD (id: 53730)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.